Shawn O’Brien

The Canadian pharmaceutical landscape is undergoing a “biologic revolution,” and there’s no end in sight. How will pharmacy care models adapt? Biologic or “biotech” drugs are continuing to increase, both in terms of utilization and as a percentage of overall pharmacy expenditures. Pharmacy benefit managers such as Caremark and ESI report that in the U.S., […]

  • November 1, 2007 September 13, 2019
  • 00:00

© Copyright 2006 Rogers Publishing Ltd. The following article first appeared in the January 2006 edition of BENEFITS CANADA magazine. A bitter pill   Plan sponsors in Canada can learn a thing or two from their U.S. counterparts about managing drug benefit programs.   By Shawn O’Brien Whether you are an employer in Canada or the […]

  • January 1, 2006 September 13, 2019
  • 00:00